|
1
|
Bergfeld SA and DeClerck YA: Bone
marrow-derived mesenchymal stem cells and the tumor
microenvironment. Cancer Metastasis Rev. 29:249–261. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cukierman E and Bassi DE: The mesenchymal
tumor microenvironment: A drug-resistant niche. Cell Adh Migr.
6:285–296. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barcellos-de-Souza P, Gori V, Bambi F and
Chiarugi P: Tumor microenvironment: Bone marrow-mesenchymal stem
cells as key players. Biochim Biophys Acta. 1836:321–335.
2013.PubMed/NCBI
|
|
4
|
Simons M and Raposo G: Exosome-vesicular
carriers for intercellular communication. Curr Opin Cell Biol.
21:575–581. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pap E, Pállinger E, Pásztói M and Falus A:
Highlights of a new type of intercellular communication:
Microvesicle-based information transfer. Inflamm Res. 58:1–8. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Taverna S, Flugy A, Saieva L, Kohn EC,
Santoro A, Meraviglia S, De Leo G and Alessandro R: Role of exosome
released by chronic myelogenous leukemia cells in angiogenesis. Int
J Cancer. 130:2033–2043. 2012. View Article : Google Scholar
|
|
7
|
Hood JL, San RS and Wickline SA: Exosome
released by melanoma cells prepare sentinel lymph nodes for tumor
metastasis. Cancer Res. 71:3792–3801. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ji R, Zhang B, Zhang X, Xue J, Yuan X, Yan
Y, Wang M, Zhu W, Qian H and Xu W: Exosomes derived from human
mesenchymal stem cells confer drug resistance in gastric cancer.
Cell Cycle. 14:2473–2483. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou W, Fong MY, Min Y, Somlo G, Liu L,
Palomares MR, Yu Y, Chow A, O'Connor ST, Chin AR, et al:
Cancer-secreted miR-105 destroys vascular endothelial barriers to
promote metastasis. Cancer cell. 25:501–515. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boelens MC, Wu TJ, Nabet BY, Xu B, Qiu Y,
Yoon T, Azzam DJ, Twyman-Saint Victor C, Wiemann BZ, Ishwaran H, et
al: Exosome transfer from stromal to breast cancer cells regulates
therapy resistance pathways. Cell. 159:499–513. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang M, Gu H, Wang S, Qian H, Zhu W, Zhang
L, Zhao C, Tao Y and Xu W: Circulating miR-17-5p and miR-20a:
Molecular markers for gastric cancer. Mol Med Rep. 5:1514–1520.
2012.PubMed/NCBI
|
|
12
|
Zhu W, Huang L, Li Y, Zhang X, Gu J, Yan
Y, Xu X, Wang M, Qian H and Xu W: Exosomes derived from human bone
marrow mesenchymal stem cells promote tumor growth in vivo. Cancer
Lett. 315:28–37. 2012. View Article : Google Scholar
|
|
13
|
Gu J, Qian H, Shen L, Zhang X, Zhu W,
Huang L, Yan Y, Mao F, Zhao C, Shi Y and Xu W: Gastric cancer
exosomes trigger differentiation of umbilical cord derived
mesenchymal stem cells to carcinoma-associated fibroblasts through
TGF-β/Smad pathway. PLoS One. 7:e524652012. View Article : Google Scholar
|
|
14
|
Li T, Yan Y, Wang B, Qian H, Zhang X, Shen
L, Wang M, Zhou Y, Zhu W, Li W and Xu W: Exosomes derived from
human umbilical cord mesenchymal stem cells alleviate liver
fibrosis. Stem Cells Dev. 22:845–854. 2013. View Article : Google Scholar :
|
|
15
|
Zhu W, Huang L, Li Y, Qian H, Shan X, Yan
Y, Mao F, Wu X and Xu WR: Mesenchymal stem cell-secreted soluble
signaling molecules potentiate tumor growth. Cell Cycle.
10:3198–3207. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Savagner P: The epithelial-mesenchymal
transition (EMT) phenomenon. Ann Oncol. 21(Suppl 7): vii89–vii92.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schlessinger J: Common and distinct
elements in cellular signaling via EGF and FGF receptors. Science.
306:1506–1507. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Y, Zhang J, Xu K, Xiao Z, Sun J, Xu
J, Wang J and Tang Q: PTEN/PI3K/mTOR/B7-H1 signaling pathway
regulates cell progression and immuno-resistance in pancreatic
cancer. Hepatogastroenterology. 60:1766–1772. 2013.
|
|
19
|
Gargini R, Cerliani JP, Escoll M, Antón IM
and Wandosell F: Cancer stem cell-like phenotype and survival are
coordinately regulated by Akt/FoxO/Bim pathway. Stem Cells.
33:646–660. 2015. View Article : Google Scholar
|
|
20
|
Davis WJ, Lehmann PZ and Li W: Nuclear
PI3K signaling in cell growth and tumorigenesis. Front Cell Dev
Biol. 3:242015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang Y, Otte A and Hass R: Human
mesenchymal stroma/stem cells exchange membrane proteins and alter
functionality during interaction with different tumor cell lines.
Stem Cells Dev. 24:1205–1222. 2015. View Article : Google Scholar :
|
|
22
|
Lee JK, Park SR, Jung BK, Jeon YK, Lee YS,
Kim MK, Kim YG, Jang JY and Kim CW: Exosomes derived from
mesenchymal stem cells suppress angiogenesis by down-regulating
VEGF expression in breast cancer cells. PLoS One. 8:e842562013.
View Article : Google Scholar
|
|
23
|
Lin R, Wang S and Zhao RC: Exosomes from
human adipose-derived mesenchymal stem cells promote migration
through Wnt signaling pathway in a breast cancer cell model. Mol
Cell Biochem. 383:13–20. 2013. View Article : Google Scholar : PubMed/NCBI
|
